6ER-010 Focus on hcv treatment based on second-generation direct-acting antiviral agents (daas-2): comparing national and local prescribing trends

BACKGROUND: Since the beginning of 2014, an increasing number of second-generation direct-acting antiviral agents (DAAs) have been approved in Italy for treating chronic hepatitis C virus (HCV) improving patients’ perspectives and increasing treatment outcomes. In order to achieve high-quality treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Hosp Pharm
Hlavní autoři: Inserra, C, Zovi, A, Scalzi, V, Zampogna, L, Vimercati, S, Piacenza, M, Zerega, G
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2018
Témata:
Section 6: Education and research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535159/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.503
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky